SecBot SecBot
SECBOTREPLAY Home › Report › MIRM

MIRM · Director Saira Ramasastry filed a Form 144 notice of intent to sell…

Mirum Pharmaceuticals, Inc. · 144 filed Jun 1, 2026 at 16:04 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 1, 2026 at 16:04 ET

Director Saira Ramasastry filed a Form 144 notice of intent to sell 3,977 shares of Mirum Pharmaceuticals common stock, valued at approximately $397,700 based on the filing date. This is a modest sale relative to the company's $6.2B market cap and follows a pattern of regular monthly sales by the director (2,000 shares each in March, April, and May 2026). The filing is routine and does not signal material insider concern.

  • Director Saira Ramasastry filed Form 144 to sell 3,977 shares of MIRM common stock.
  • Estimated sale value is approximately $397,700 based on filing date.
  • Ramasastry has sold 2,000 shares per month in March, April, and May 2026, suggesting a pre-planned trading pattern.
  • The sale represents a tiny fraction of the company's $6.2B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access